Clinical Trial Update: 18F-FAPI PET in Cancers of Unknown Primary Site

View source ↗

Summary

Clinical trial update on using 18F-FAPI PET imaging in cancers of unknown primary site. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Unknown Primary Site

Drugs mentioned

• 18F-FAPI PET (Fibroblast Activation Protein Inhibitor Radiotracer)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Cancer of Unknown Primary Site | Status: NOT_YET_RECRUITING